Developer docs
API playgroundTry for free, no card

Search company profiles

RYMO

Full company profile

uuid000bd8p

Namestring
RYMO
Legal namestring
Rymo Technologies Pvt. Ltd.
Websiteurl
rymo.in
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Rymo Technologies Pvt. Ltd. is a Navi Mumbai, India-based medical device company founded in 2020 by Chirag Shah and Abhishek Rai that develops clinically validated, CDSCO-certified and US FDA Class II-cleared rehabilitation robotics for neurological, orthopedic, and physiotherapy applications. The company sells three core products: MOBI-L, a patented portable multi-limb robotic rehabilitation device combining assistive and resistive therapy with VR-based functional task training and real-time biofeedback; MEND, a digital balance board using visual and audio feedback for static and dynamic balance rehabilitation; and NUDGE, positioned as India's first light-based gamified system for cognitive training, reflex enhancement, and reaction time assessment. Underlying capabilities include 20+ exercises, 7+ joint protocols, 12+ gamified exercises with progressive challenge levels, and session-level quantitative data capture covering ROM, strength, speed, and reaction time, with EMR-ready automated reporting.

Rymo has deployed 452 devices across 354 clinical customers including AIIMS, Apollo Hospitals, and Manipal Hospitals, and supports a network of 328+ certified clinics across 45+ Indian cities, having enabled 50,000+ therapy sessions and treatment of 7,500+ patients. The revenue model is primarily hardware device sales to hospitals and rehabilitation centers, supplemented by flexible leasing options (with ROI claimed within 6-8 months) and recurring professional services including on-site staff certification, annual preventive maintenance, and a 24/7 technical helpdesk. Go-to-market combines direct enterprise field sales targeting hospital networks with a certified clinic channel program for mid-market physiotherapy accounts, plus a newly signed distribution partnership with Fourier Rehab for ASEAN market entry.

The company is venture-backed, having raised over Rs 10 crore (~USD 1.08 million) in a March 2026 seed round led by IAN Angel Fund with angel investor participation, and is supported by academic and innovation partnerships with IIT Bombay, IIT Madras, Social Alpha, BIRAC, NIDHI PRAYAS, GDC, and riidl. Regulatory posture is unusually strong for a seed-stage Indian medical device company, with US FDA Class II, ISO 13485:2016, IEC 60601-1, and CDSCO certifications in place, and stated intent to expand commercially into ASEAN and Middle East markets using the recent capital infusion.

Short descriptiontext

Rymo Technologies is a Navi Mumbai-based medical device company founded in 2020 that develops US FDA Class II-cleared rehabilitation robotics (MOBI-L, MEND, NUDGE) for hospitals, rehabilitation centers, and physiotherapy clinics treating neurological, orthopedic, and post-surgical patients across India and select international markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNavi Mumbai, India
HQ citystring
Navi Mumbai
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rehabilitation robotics, medical devices, neuro-rehabilitation systems, balance training equipment, physical therapy technology
Industry4 codes
PRIMARYHLAHAMAG
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYHLACANAJ
Digital Rehabilitation & Physical Therapy Therapeutics
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHSADAIAC
Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS)
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise
SECONDARYHLALABAK
Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)541715
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Rehabilitation Robotics & Medical Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Hardware Sales
TypeHardware Sales
Description

Sale of rehabilitation robotics devices (MOBI-L, MEND, NUDGE) to healthcare facilities including hospitals, clinics, and rehabilitation centers. One-time capital purchase model with device sales.

rymo.in
2Flexible Leasing Models
TypeSubscription Recurring
Description

Flexible leasing options for healthcare facilities. Website mentions 'ROI within 06-08 months' indicating financing/lease options are available to lower upfront capital requirements for customers.

rymo.in
3Professional Services and Training
TypeProfessional Services
Description

On-site staff certification, annual preventive maintenance, and 24/7 technical helpdesk services provided as part of device deployment and ongoing support.

rymo.in
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Others
Pricing details1 tier
1Hardware device purchase model with flexible financing options
ModelUnit PricingBilling cadenceMulti-year contract
Notes

Device purchase with flexible leasing models available. ROI projected within 06-08 months. No specific pricing tiers disclosed publicly.

rymo.in
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1MOBI-L
Description

Portable, Patented Multi-Limb Robotic Rehabilitation device for upper limb, lower limb, and ADL training with VR-based therapy.

rymo.in
+2 more records
Core offering1 text field

RYMO designs, manufactures, and sells clinically validated rehabilitation robotics devices — MOBI-L (portable multi-limb robotic rehab with VR therapy), MEND (digital balance board), and NUDGE (light-based cognitive/reflex training system) — for hospitals, rehabilitation centers, and physiotherapy clinics. The devices combine robotics, AI-driven adaptive resistance, real-time biofeedback, gamification, and EMR-ready data analytics to deliver high-intensity, measurable neuro-rehabilitation, orthopedic, oncology, and cardiac therapy. RYMO also provides flexible leasing, on-site staff certification, annual preventive maintenance, and 24/7 technical helpdesk as part of its deployment model.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 85% improvement in patient adherence
+7 more records
Product overview1 text field

Rymo Technologies offers a portfolio of three clinically validated rehabilitation robotics products: MOBI-L (portable multi-limb robotic rehabilitation device), MEND (digital balance board), and NUDGE (light-based cognition and reflex training system). The products integrate robotics, virtual reality, and gamification to support neurological, orthopedic, and physiotherapy applications across healthcare facilities.

Product and service5 records
1MOBI-L Multi-Limb Robotic Rehabilitation System
CategoryRehabilitation Robotics Hardware
Description

Portable, patented multi-limb robotic rehabilitation device for upper limb, lower limb, and ADL training, combining assistive, resistive, and VR-based therapy with 20+ exercises, 10+ attachments, 7+ joint protocols, real-time biofeedback, adaptive resistance, and 12+ gamified exercises. Designed for hospitals, rehabilitation centers, and physiotherapy clinics treating stroke, TBI, spinal cord injury, Parkinson's, and orthopedic conditions.

2MEND Digital Balance Board
CategoryRehabilitation Robotics Hardware
Description

Portable digital balance trainer for static and dynamic balance rehabilitation, using multi-directional movement analysis, real-time visual and audio feedback, and gamified therapeutic interventions. Targets hospitals and clinics treating stroke, Parkinson's, fall-risk elderly, sports rehab, and orthopedic balance deficits.

3NUDGE Game-Based Cognition & Reflex Training System
CategoryRehabilitation Robotics Hardware
Description

India's first light-based, wireless, subscription-free gamified system for cognitive training, reflex enhancement, agility, and reaction time assessment, with upper and lower limb motor engagement. Used by physiotherapy and neuro-rehabilitation clinics to improve brain-body coordination.

4Rymo Professional Services and Training
CategoryProfessional Services
Description

On-site staff certification, annual preventive maintenance, and 24/7 technical helpdesk support provided to healthcare facilities purchasing MOBI-L, MEND, and NUDGE devices, supporting clinical adoption and ongoing uptime.

5Rymo Flexible Leasing Program
CategoryDevice Leasing / Subscription Financing
Description

Multi-year flexible leasing/financing option for MOBI-L, MEND, and NUDGE devices, lowering upfront capital outlay for hospitals and rehabilitation clinics with claimed ROI within 6-8 months.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-01
Description

Distribution partnership signed with Fourier Rehab for ASEAN market expansion. Supports Rymo's international scaling strategy beyond India into Southeast Asian markets.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Academic collaboration with IIT Bombay for research and development in rehabilitation technology

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Academic collaboration with IIT Madras supporting research and development initiatives

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Academic and innovation partnership supporting technology development and market access

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Government-funded biotechnology and pharmaceutical research organization partnership supporting healthcare innovation

6NIDHI PRAYAS
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Startup incubation program partnership supporting technology development and commercialization

rymo.in
7GDC
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Academic institution partnership supporting rehabilitation technology research

rymo.in
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Innovation and startup ecosystem partnership supporting technology commercialization

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

China-based global leader in rehabilitation robotics offering upper-limb, lower-limb, and balance devices. Rymo's ASEAN distribution partnership with Fourier Rehab creates direct commercial overlap; product portfolios (multi-limb robotics + VR) are closely aligned.

TypeDirect peer
Description

US-listed developer of robotic exoskeletons for stroke and spinal cord injury rehabilitation. Comparable target customers (hospitals, rehab centers) and FDA-cleared Class II medical device regulatory positioning.

TypeDirect peer
Description

Austrian manufacturer of robotic and sensor-based therapy devices for upper extremity and balance rehabilitation. Closely comparable to MOBI-L and MEND in functionality and customer base.

4Hocoma (DIH)
TypeDirect peer
Description

Swiss-origin global leader in robotic and sensor-based rehabilitation devices (Lokomat, Armeo). Competes head-to-head with MOBI-L in hospital neuro-rehab settings and sets the benchmark for clinical evidence and pricing.

5Bionik Laboratories
TypeDirect peer
Description

Robotic upper-limb rehabilitation devices for neurological patients. Direct overlap with Rymo's MOBI-L upper-limb therapy positioning and similar clinical evidence-led go-to-market.

TypeEmerging player
Description

US-based developer of upper-limb rehabilitation devices and orthoses for stroke survivors. Comparable focus on neuro-rehab patient outcomes and therapist productivity, though primarily non-robotic devices.

TypeDirect peer
Description

Developer of exoskeleton systems for spinal cord injury and stroke rehabilitation. Overlaps in neuro-rehab hospital channel and FDA Class II medical device category.

TypeEmerging player
Description

Spain-based startup developing robotic exoskeletons for gait rehabilitation in hospitals. Comparable stage and technology overlap with Rymo's lower-limb robotic rehab roadmap.

TypeEmerging player
Description

US-based startup developing upper-extremity robotic rehabilitation devices. Similar product positioning to MOBI-L for stroke and neurological indications, comparable company stage.

TypeOthers
Description

Adjacent rehabilitation technology provider. Thematically related to rehab services but focused on healthcare consulting rather than robotic devices; included as ecosystem participant.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RYMO

Rehabilitation Robotics & Medical Devicesrymo.in

Rymo Technologies is a Navi Mumbai-based medical device company founded in 2020 that develops US FDA Class II-cleared rehabilitation robotics (MOBI-L, MEND, NUDGE) for hospitals, rehabilitation centers, and physiotherapy clinics treating neurological, orthopedic, and post-surgical patients across India and select international markets.

What RYMO does

Rymo Technologies Pvt. Ltd. is a Navi Mumbai, India-based medical device company founded in 2020 by Chirag Shah and Abhishek Rai that develops clinically validated, CDSCO-certified and US FDA Class II-cleared rehabilitation robotics for neurological, orthopedic, and physiotherapy applications. The company sells three core products: MOBI-L, a patented portable multi-limb robotic rehabilitation device combining assistive and resistive therapy with VR-based functional task training and real-time biofeedback; MEND, a digital balance board using visual and audio feedback for static and dynamic balance rehabilitation; and NUDGE, positioned as India's first light-based gamified system for cognitive training, reflex enhancement, and reaction time assessment. Underlying capabilities include 20+ exercises, 7+ joint protocols, 12+ gamified exercises with progressive challenge levels, and session-level quantitative data capture covering ROM, strength, speed, and reaction time, with EMR-ready automated reporting.

Rymo has deployed 452 devices across 354 clinical customers including AIIMS, Apollo Hospitals, and Manipal Hospitals, and supports a network of 328+ certified clinics across 45+ Indian cities, having enabled 50,000+ therapy sessions and treatment of 7,500+ patients. The revenue model is primarily hardware device sales to hospitals and rehabilitation centers, supplemented by flexible leasing options (with ROI claimed within 6-8 months) and recurring professional services including on-site staff certification, annual preventive maintenance, and a 24/7 technical helpdesk. Go-to-market combines direct enterprise field sales targeting hospital networks with a certified clinic channel program for mid-market physiotherapy accounts, plus a newly signed distribution partnership with Fourier Rehab for ASEAN market entry.

The company is venture-backed, having raised over Rs 10 crore (~USD 1.08 million) in a March 2026 seed round led by IAN Angel Fund with angel investor participation, and is supported by academic and innovation partnerships with IIT Bombay, IIT Madras, Social Alpha, BIRAC, NIDHI PRAYAS, GDC, and riidl. Regulatory posture is unusually strong for a seed-stage Indian medical device company, with US FDA Class II, ISO 13485:2016, IEC 60601-1, and CDSCO certifications in place, and stated intent to expand commercially into ASEAN and Middle East markets using the recent capital infusion.

RYMO firmographics

Firmographics
Name
RYMO
Legal name
Rymo Technologies Pvt. Ltd.
Website
https://rymo.in
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Rymo Technologies is a Navi Mumbai-based medical device company founded in 2020 that develops US FDA Class II-cleared rehabilitation robotics (MOBI-L, MEND, NUDGE) for hospitals, rehabilitation centers, and physiotherapy clinics treating neurological, orthopedic, and post-surgical patients across India and select international markets.
Ownership category
akta.pro rank

RYMO industry classification

Industry
Product category
Rehabilitation Robotics & Medical Devices
NAICS
Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHAMAG
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYHLACANAJ
Digital Rehabilitation & Physical Therapy Therapeutics
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHSADAIAC
Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS)
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise
SECONDARYHLALABAK
Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)

Keywords

  • Rehabilitation robotics
  • Medical devices
  • Neuro-rehabilitation systems
  • Balance training equipment
  • Physical therapy technology

Where RYMO is headquartered

Location

Headquarters

HQ city
Navi Mumbai
HQ country
India
HQ region
Asia

Offices1 record

Markets served

RYMO business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Medical Device Hardware Sales: Sale of rehabilitation robotics devices (MOBI-L, MEND, NUDGE) to healthcare facilities including hospitals, clinics, and rehabilitation centers. One-time capital purchase model with device sales.
  2. Flexible Leasing Models: Flexible leasing options for healthcare facilities. Website mentions 'ROI within 06-08 months' indicating financing/lease options are available to lower upfront capital requirements for customers.
  3. Professional Services and Training: On-site staff certification, annual preventive maintenance, and 24/7 technical helpdesk services provided as part of device deployment and ongoing support.

Pricing tiers

ModelBillingPrice
Unit PricingMulti-year contractHardware device purchase model with flexible financing options

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

RYMO product offering

Product offering

Core offering

RYMO designs, manufactures, and sells clinically validated rehabilitation robotics devices — MOBI-L (portable multi-limb robotic rehab with VR therapy), MEND (digital balance board), and NUDGE (light-based cognitive/reflex training system) — for hospitals, rehabilitation centers, and physiotherapy clinics. The devices combine robotics, AI-driven adaptive resistance, real-time biofeedback, gamification, and EMR-ready data analytics to deliver high-intensity, measurable neuro-rehabilitation, orthopedic, oncology, and cardiac therapy. RYMO also provides flexible leasing, on-site staff certification, annual preventive maintenance, and 24/7 technical helpdesk as part of its deployment model.

Product overview

Rymo Technologies offers a portfolio of three clinically validated rehabilitation robotics products: MOBI-L (portable multi-limb robotic rehabilitation device), MEND (digital balance board), and NUDGE (light-based cognition and reflex training system). The products integrate robotics, virtual reality, and gamification to support neurological, orthopedic, and physiotherapy applications across healthcare facilities.

Differentiator

Problem solved

Functional benefit

Brands

  • MOBI-L: Portable, Patented Multi-Limb Robotic Rehabilitation device for upper limb, lower limb, and ADL training with VR-based therapy.
  • MEND
  • NUDGE

Products and services

  • MOBI-L Multi-Limb Robotic Rehabilitation System Portable, patented multi-limb robotic rehabilitation device for upper limb, lower limb, and ADL training, combining assistive, resistive, and VR-based therapy with 20+ exercises, 10+ attachments, 7+ joint protocols, real-time biofeedback, adaptive resistance, and 12+ gamified exercises. Designed for hospitals, rehabilitation centers, and physiotherapy clinics treating stroke, TBI, spinal cord injury, Parkinson's, and orthopedic conditions.
  • MEND Digital Balance Board Portable digital balance trainer for static and dynamic balance rehabilitation, using multi-directional movement analysis, real-time visual and audio feedback, and gamified therapeutic interventions. Targets hospitals and clinics treating stroke, Parkinson's, fall-risk elderly, sports rehab, and orthopedic balance deficits.
  • NUDGE Game-Based Cognition & Reflex Training System India's first light-based, wireless, subscription-free gamified system for cognitive training, reflex enhancement, agility, and reaction time assessment, with upper and lower limb motor engagement. Used by physiotherapy and neuro-rehabilitation clinics to improve brain-body coordination.
  • Rymo Professional Services and Training On-site staff certification, annual preventive maintenance, and 24/7 technical helpdesk support provided to healthcare facilities purchasing MOBI-L, MEND, and NUDGE devices, supporting clinical adoption and ongoing uptime.
  • Rymo Flexible Leasing Program Multi-year flexible leasing/financing option for MOBI-L, MEND, and NUDGE devices, lowering upfront capital outlay for hospitals and rehabilitation clinics with claimed ROI within 6-8 months.

Quantifiable outcome

  • 85% improvement in patient adherence
  • +7 more outcomes

Companies that use RYMO

Customer profile

Named customers8 records

Segments6 records

Ideal customer profiles3 records

RYMO technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

RYMO partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and supporting.

  • Fourier RehabcoreChannel Partner/ Reseller/ Distributor · 1 March 2026Distribution partnership signed with Fourier Rehab for ASEAN market expansion. Supports Rymo's international scaling strategy beyond India into Southeast Asian markets.
  • IIT BombaysupportingStrategic or Co-development PartnerAcademic collaboration with IIT Bombay for research and development in rehabilitation technology
  • IIT MadrassupportingStrategic or Co-development PartnerAcademic collaboration with IIT Madras supporting research and development initiatives
  • Social AlphasupportingStrategic or Co-development PartnerAcademic and innovation partnership supporting technology development and market access
  • BIRACsupportingStrategic or Co-development PartnerGovernment-funded biotechnology and pharmaceutical research organization partnership supporting healthcare innovation
  • NIDHI PRAYASsupportingStrategic or Co-development PartnerStartup incubation program partnership supporting technology development and commercialization
  • GDCsupportingStrategic or Co-development PartnerAcademic institution partnership supporting rehabilitation technology research
  • riidlsupportingStrategic or Co-development PartnerInnovation and startup ecosystem partnership supporting technology commercialization

Scale indicators10 records

Recent moves5 records

Expansion highlights6 records

RYMO competitors and assessment

Company assessment

Direct peers

  • Fourier Intelligence: China-based global leader in rehabilitation robotics offering upper-limb, lower-limb, and balance devices. Rymo's ASEAN distribution partnership with Fourier Rehab creates direct commercial overlap; product portfolios (multi-limb robotics + VR) are closely aligned.
  • Ekso Bionics: US-listed developer of robotic exoskeletons for stroke and spinal cord injury rehabilitation. Comparable target customers (hospitals, rehab centers) and FDA-cleared Class II medical device regulatory positioning.
  • Tyromotion: Austrian manufacturer of robotic and sensor-based therapy devices for upper extremity and balance rehabilitation. Closely comparable to MOBI-L and MEND in functionality and customer base.
  • Hocoma (DIH): Swiss-origin global leader in robotic and sensor-based rehabilitation devices (Lokomat, Armeo). Competes head-to-head with MOBI-L in hospital neuro-rehab settings and sets the benchmark for clinical evidence and pricing.
  • Bionik Laboratories: Robotic upper-limb rehabilitation devices for neurological patients. Direct overlap with Rymo's MOBI-L upper-limb therapy positioning and similar clinical evidence-led go-to-market.
  • ReWalk Robotics: Developer of exoskeleton systems for spinal cord injury and stroke rehabilitation. Overlaps in neuro-rehab hospital channel and FDA Class II medical device category.

Emerging players

  • Saebo: US-based developer of upper-limb rehabilitation devices and orthoses for stroke survivors. Comparable focus on neuro-rehab patient outcomes and therapist productivity, though primarily non-robotic devices.
  • ABLE Human Motion: Spain-based startup developing robotic exoskeletons for gait rehabilitation in hospitals. Comparable stage and technology overlap with Rymo's lower-limb robotic rehab roadmap.
  • Harmonic Bionics: US-based startup developing upper-extremity robotic rehabilitation devices. Similar product positioning to MOBI-L for stroke and neurological indications, comparable company stage.

Others

  • Maxwell Healthcare Associates: Adjacent rehabilitation technology provider. Thematically related to rehab services but focused on healthcare consulting rather than robotic devices; included as ecosystem participant.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

RYMO social profiles

Digital presence

RYMO compliance and trust

Trust signal

Compliance4 records

RYMO financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RYMO leadership team

Management profile

Number of profiles

Profiles2 records

RYMO funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RYMO M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RYMO

What does RYMO do?

RYMO designs, manufactures, and sells clinically validated rehabilitation robotics devices — MOBI-L (portable multi-limb robotic rehab with VR therapy), MEND (digital balance board), and NUDGE (light-based cognitive/reflex training system) — for hospitals, rehabilitation centers, and physiotherapy clinics. The devices combine robotics, AI-driven adaptive resistance, real-time biofeedback, gamification, and EMR-ready data analytics to deliver high-intensity, measurable neuro-rehabilitation, orthopedic, oncology, and cardiac therapy. RYMO also provides flexible leasing, on-site staff certification, annual preventive maintenance, and 24/7 technical helpdesk as part of its deployment model.

Is RYMO a public or private company?

RYMO is a private company. It is classified as venture growth investor backed and is currently operating.

When was RYMO founded?

RYMO was founded in 2020. It employs 11 to 50 people.

Where is RYMO based?

RYMO is headquartered in Navi Mumbai, India, in the Asia region.

How does RYMO make money?

Three revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are flexible Leasing Models and professional Services and Training.

Who are RYMO's main competitors?

Direct peers on record are Fourier Intelligence, Ekso Bionics, Tyromotion, Hocoma (DIH), Bionik Laboratories and ReWalk Robotics. Emerging players are Saebo, ABLE Human Motion and Harmonic Bionics. Maxwell Healthcare Associates is listed as an others.

Does RYMO have an API?

No public API is recorded for RYMO.

What industry is RYMO in?

RYMO's product category is Rehabilitation Robotics & Medical Devices. Its primary akta.pro industry code is HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices), with a secondary code of HLACANAJ, Digital Rehabilitation & Physical Therapy Therapeutics. Its NAICS code is 5417 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Digital Health News1Crowd Invests in Rymo Technologies to Expand Healthcare Portfolio1Crowd invested in Rymo Technologies, a healthtech startup developing robotic rehabilitation systems for India. The investment aims to expand 1Crowd's healthcare portfolio and support Rymo's robotics, AI, and gamification-based solutions for physiotherapy clinics and hospitals.BusinessLine1Crowd invests in Rymo Technologies for affordable robotic rehabilitation1Crowd invested in Rymo Technologies, a health tech firm developing robotic rehabilitation systems and AI-based therapy tools. Rymo's products cost 10-20% of imported competitors, targeting smaller hospitals and physiotherapy centers. The investment is part of 1Crowd's healthcare and medtech portfolio, which holds about 20% of its funds.The Tribune1Crowd Expands Healthcare Portfolio with Rymo Technologies - The Tribune1Crowd, an Indian early-stage investment fund, added Rymo Technologies to its healthcare portfolio. Rymo offers robotic rehabilitation systems at 10-20% of foreign competitors' prices, targeting mid-sized hospitals and smaller physiotherapy centers. The investment reflects 1Crowd's focus on affordable, India-built healthcare technology.Dealroom.co1Crowd leads early VC round in India's Rymo Technologies | Dealroom News1Crowd led an early-stage venture round in Rymo Technologies, an Indian health-tech firm building robotic and AI-driven rehabilitation systems. The investment, announced in November 2026, follows a US$1.36M seed round and aims to make robotic rehab 10 times cheaper than imported systems. The company targets smaller physiotherapy centres and homes, with functional electrical stimulation devices in development.Business Standard1Crowd Expands Healthcare Portfolio with Rymo Technologies1Crowd, an Indian early-stage investment fund, added Rymo Technologies to its healthcare portfolio. Rymo offers robotic rehabilitation systems at 10-20% of foreign competitors' costs, targeting mid-sized hospitals and smaller clinics. The investment reflects 1Crowd's focus on affordable, India-built health-tech.Devdiscourse1Crowd Expands Healthcare Portfolio with Rymo Technologies1Crowd, an Indian early-stage investment fund, added Rymo Technologies to its healthcare portfolio. Rymo offers robotic rehabilitation systems costing 10-20% of imported alternatives, targeting smaller hospitals and physiotherapy centers. The investment reflects 1Crowd's focus on affordable, India-built health-tech.The Tribune1Crowd Expands Healthcare Portfolio with Rymo Technologies - The Tribune1Crowd, an Indian early-stage investment fund, added Rymo Technologies to its healthcare portfolio. Rymo offers robotic rehabilitation systems at 10-20% of foreign competitors' prices, targeting mid-sized hospitals and smaller physiotherapy centers. The investment reflects 1Crowd's focus on affordable, India-built healthcare technology.BwdisruptIAN Group Backs Rymo Technologies In Rs 10 Cr Seed Funding RoundIAN Group invested in robotic neuro-rehabilitation startup Rymo Technologies as part of a seed funding round of over Rs 10 crore through its IAN Angel Fund, along with other angel investors. Rymo Technologies plans to deploy the fresh capital to accelerate product innovation, expand manufacturing capabilities, strengthen its India presence, and scale into ASEAN and Middle East markets, building on 450+ device installations and 350+ clinical customers including AIIMS, Apollo Hospitals, and Manipal Hospitals. The startup has supported over 7,500 patients and delivered more than 15,000 therapy hours, having secured US FDA Class II medical device classification.BwdisruptIAN Angel Fund Leads Rs 10 Cr Seed Round In Healthtech Startup Rymo TechnologiesIAN Angel Fund, through IAN Group, has led a seed funding round of over Rs 10 crore in Rymo Technologies, a robotic neuro-rehabilitation startup, with participation from angel investors. The capital will accelerate product innovation, expand manufacturing capabilities, and support Rymo's presence in India while scaling into ASEAN and Middle East markets. Rymo has received US FDA Class II medical device classification and signed a distribution partnership with Fourier Rehab for ASEAN expansion.VCCircleRymo, DeepLase pocket early-stage cheques; TransTech inks M&ANeuro-rehabilitation startup Rymo Technologies raised Rs 10 crore (over $1 million) in a seed round from IAN Group and angel investors, while photonics startup DeepLase Technologies secured Rs 6 crore in seed funding co-led by Mounttech Growth Fund-Kavachh and Yali Capital. Separately, TransTech Group acquired a controlling stake in Teknoflow Green Equipments, a Nashik-based engineered fabrication and process equipment manufacturer founded in 1989 that serves customers across over 25 countries.